How Clinical Trials Help Kirk Smith Live with Stage IIIb Lung Cancer

Kirk Smith is the 2016 featured PPD Hero. Smith was diagnosed with stage IIIb lung cancer with an ALK+ mutation, which is one of the rarest genetic mutations for lung cancer nonsmokers and has a five-year survival rate of five percent. He credits clinical research for saving lives and for his being alive nearly three years after his lung cancer diagnosis. He will race the 2016 PPD® IRONMAN® 70.3® North Carolina triathlon presented by New Hanover Regional Medical Center.


Featured Content

Are you a patient with lung cancer?

Please add your voice as an advocate today to help raise awareness about some of the issues commonly faced.

Learn more

Featured by HealthUnlocked

1 Reply

  • Thank you for posting this inspiring video. Go Kirk!

You may also like...